Last reviewed · How we verify
Standard Dose Ibuprofen
Standard Dose Ibuprofen is a Nonsteroidal anti-inflammatory drug (NSAID) Small molecule drug developed by Ottawa Hospital Research Institute. It is currently FDA-approved for Mild to moderate pain, Fever reduction, Inflammation associated with arthritis and musculoskeletal conditions.
Ibuprofen inhibits cyclooxygenase (COX) enzymes to reduce the production of prostaglandins, thereby decreasing inflammation, pain, and fever.
Standard dose ibuprofen is a small molecule that inhibits the enzyme cyclooxygenase, which is involved in the production of prostaglandins. It is used to manage conditions such as acute post-operative pain, post-operative pain, and possibly other conditions including obesity and post-bariatric surgery pain, as indicated by clinical trials.
At a glance
| Generic name | Standard Dose Ibuprofen |
|---|---|
| Sponsor | Ottawa Hospital Research Institute |
| Drug class | Nonsteroidal anti-inflammatory drug (NSAID) |
| Target | COX-1, COX-2 |
| Modality | Small molecule |
| Therapeutic area | Pain Management, Inflammation |
| Phase | FDA-approved |
Mechanism of action
Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that non-selectively blocks COX-1 and COX-2 enzymes, which are responsible for synthesizing prostaglandins—key mediators of inflammation, pain, and fever. By reducing prostaglandin levels in affected tissues, ibuprofen provides analgesic, anti-inflammatory, and antipyretic effects. It is widely used for mild to moderate pain and inflammatory conditions.
Approved indications
- Mild to moderate pain
- Fever reduction
- Inflammation associated with arthritis and musculoskeletal conditions
Common side effects
- Gastrointestinal upset (nausea, dyspepsia, abdominal pain)
- Headache
- Dizziness
- Rash
- Gastrointestinal bleeding (with chronic use)
- Cardiovascular events (with chronic use)
Key clinical trials
- ERAS (Enhanced Recovery After Surgery) and Multimodal Analgesia in Laparoscopic Cholecystectomy
- Musculoskeletal Outcomes Using Tylenol/Ibuprofen vs. Oral Steroids in New Injuries (PHASE4)
- Comparison of M-TAPA and TAP Blocks on Postoperative Analgesia in Laparoscopic Inguinal Hernia Surgeries (NA)
- Two Post-Operative Pain Protocols at Discharge for Orthopaedic Patients (NA)
- Psychosocial Factors and Postoperative Pain in Aesthetic Breast Surgery
- The Effect of Multimodal Pain Regimen on Use of Narcotics After Rotator Cuff Tear Repair (PHASE4)
- Ultrasound-Guided Regional Blocks for Postoperative Analgesia After Laparoscopic Cholecystectomy (NA)
- Reduced Opioid Prescription After Laparoscopic Hysterectomy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Standard Dose Ibuprofen CI brief — competitive landscape report
- Standard Dose Ibuprofen updates RSS · CI watch RSS
- Ottawa Hospital Research Institute portfolio CI
Frequently asked questions about Standard Dose Ibuprofen
What is Standard Dose Ibuprofen?
How does Standard Dose Ibuprofen work?
What is Standard Dose Ibuprofen used for?
Who makes Standard Dose Ibuprofen?
What drug class is Standard Dose Ibuprofen in?
What development phase is Standard Dose Ibuprofen in?
What are the side effects of Standard Dose Ibuprofen?
What does Standard Dose Ibuprofen target?
Related
- Drug class: All Nonsteroidal anti-inflammatory drug (NSAID) drugs
- Target: All drugs targeting COX-1, COX-2
- Manufacturer: Ottawa Hospital Research Institute — full pipeline
- Therapeutic area: All drugs in Pain Management, Inflammation
- Indication: Drugs for Mild to moderate pain
- Indication: Drugs for Fever reduction
- Indication: Drugs for Inflammation associated with arthritis and musculoskeletal conditions
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing